B
Puma Biotechnology, Inc. PBYI
$5.12 -$0.09-1.73% NASDAQ
Recommendation
Prev Close
$5.12
Volume
429,290
Avg Vol (90D)
530,924
Market Cap
$257.90M
Dividend & Yield
--
52-Week Range
$2.32 - $6.07
P/E (TTM)
5.22
EPS (TTM)
$0.98
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Lesser-Known Breast Cancer Spreading Among American Women
10/11/2025 - Zero Hedge
Puma Biotechnology (NASDAQ:PBYI) Raised to Buy (B-) at Weiss Ratings
10/10/2025 - MarketBeat
CRISPR Therapeutics (CRSP) Surges 8.7%: Is This an Indication of Further Gains?
10/9/2025 - Zacks Investment Research
3 High-Flying Stocks Under $10 to Buy Hand Over Fist Right Now
10/7/2025 - 24/7 Wall St.
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
10/2/2025 - GuruFocus
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
10/2/2025 - Business Wire
Puma Biotechnology (PBYI, $5.27) RSI Indicator left the overbought zone on October 01, 2025
10/2/2025 - Tickeron - Stocks
Puma Biotechnology (PBYI, $5.31) RSI Indicator left the overbought zone on September 30, 2025
10/1/2025 - Tickeron - Stocks
Puma Biotechnology (PBYI, $5.05) Moving Average Convergence Divergence (MACD) Histogram turned positive on September 29, 2025
9/30/2025 - Tickeron - Technical Analysis
Puma Biotechnology (PBYI, $4.71) entered Uptrend as Momentum indicator ascends above 0 level on Sep 23, 2025
9/24/2025 - Tickeron - Technical Analysis
Puma Biotechnology (PBYI, $4.71) Stochastic Oscillator left the oversold zone on September 23, 2025
9/24/2025 - Tickeron - Technical Analysis
Kapitalo Investimentos Ltda Takes $241,000 Position in Puma Biotechnology, Inc. $PBYI
9/22/2025 - MarketBeat
What Do Analysts Think About Puma Biotechnology (PBYI)?
9/17/2025 - Insider Monkey
12 Affordable Biotech Stocks to Invest In Now
9/16/2025 - Insider Monkey
Does Puma Biotechnology (NASDAQ:PBYI) Have A Healthy Balance Sheet?
9/11/2025 - Simply Wall St
Puma Biotechnology, Inc. (PBYI) Presents at H.C. Wainwright 27th Annual Global Investment Conference - Slideshow
9/9/2025 - SeekingAlpha
Puma Biotechnology (NASDAQ:PBYI) Rating Increased to Strong-Buy at Wall Street Zen
9/8/2025 - MarketBeat
Puma Biotechnology (PBYI, $5.03) entered Downtrend as Momentum indicator drops below 0 level on Sep 05, 2025
9/6/2025 - Tickeron - Technical Analysis
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) PBYI Stock News
9/4/2025 - GuruFocus
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
9/4/2025 - GuruFocus
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
9/4/2025 - Business Wire
Puma Biotechnology (PBYI, $5.13) Stochastic Oscillator left the oversold zone on September 03, 2025
9/4/2025 - Tickeron - Stocks
Puma Biotechnology (PBYI, $5.11) entered Uptrend as Momentum indicator ascends above 0 level on Sep 02, 2025
9/3/2025 - Tickeron - Technical Analysis
Puma Biotechnology to Present at the H.C. Wainwright 27th Annual Global Investment Conference
9/2/2025 - GuruFocus
Puma Biotechnology to Present at the H.C. ...
9/2/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$238.06M
EBITDA (TTM)
$57.34M
EBIT (TTM)
$46.06M
Net Income (TTM)
$48.45M
Balance Sheet
Total Assets (Q)
$194.92M
Total Debt (Q)
$49.23M
Total Liabilities (Q)
$90.20M
Book Value Per Share (Q)
$2.10
Cash Flow
Cash from Operations (TTM)
$44.34M
Cash from Investing (TTM)
-$11.78M
Cash from Financing (TTM)
-$45.05M
Net Change in Cash (TTM)
-$12.49M
Filings
Filing Date
Thursday, August 7, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
0.35
7-Day Total Return
-1.92%
30-Day Total Return
1.59%
60-Day Total Return
50.59%
90-Day Total Return
43.82%
Year to Date Total Return
64.10%
1-Year Total Return
79.65%
2-Year Total Return
104.80%
3-Year Total Return
114.23%
5-Year Total Return
-47.65%
52-week Low
Nov 18, 2024 - $2.32
52-week High
Aug 18, 2025 - $6.07
Valuation
Market Cap
$257.90M - Micro Cap
Enterprise Value
$211.10M
Price/Sales (TTM)
1.08
Price/Book (Q)
2.44
Dividends and Shares
Shares Outstanding
50.14
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.pumabiotechnology.com
Phone Number
424 248 6500
Address
10880 Wilshire Boulevard
Los Angeles, CA 90024
Country
United States
Year Founded
2010
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company... more
NASDAQ 10/10/2025 4:00PM Eastern Quotes delayed